Association of MRI Indexes of the Perivascular Space Network and Cognitive Impairment in Patients with Obstructive Sleep Apnea.

Background The role of perivascular space (PVS) dysfunction in obstructive sleep apnea (OSA) requires further study. Purpose To compare MRI indexes of PVS across patients with differing severities of OSA and relate them with disease characteristics and treatment. Materials and Methods This single-center prospective study included healthy controls (HCs) and patients with complaints of snoring who underwent MRI and cognitive evaluation between June 2021 and December 2022. Participants with complaints of snoring were classified into four groups (snoring, mild OSA, moderate OSA, and severe OSA). PVS networks were assessed at MRI using PVS volume fraction, extracellular free water (FW), and diffusion tensor imaging analysis along the PVS (DTI-ALPS). One-way analysis of variance and Pearson correlation were used for analysis. Alterations in PVS indexes and cognitive performance after treatment were assessed in 15 participants with moderate OSA. Results A total of 105 participants (mean age, 33.4 years ± 8.9 [SD]; 80 males) and 50 HCs (mean age, 37.0 years ± 8.6; 33 males) were included. Higher mean PVS volume fraction was observed in participants with severe OSA ( = 23) than in patients with mild OSA ( = 36) (0.11 vs 0.10; = .03). Participants with severe OSA exhibited higher mean FW index (0.11) than both HCs (0.10; < .001) and patients with mild OSA (0.10; = .003). All patient groups had lower DTI-ALPS than HCs (range, 1.5-1.9 vs 2.1; all < .001). DTI-ALPS correlated with cognitive performance on the Stroop Color and Word Test ( range, -0.23 to -0.24; value range, .003-.005). After treatment, PVS indexes changed ( value range, <.001 to .01) and cognitive performance improved ( value range, <.001 to .03). Conclusion Differences in PVS indexes were observed among participants with differing severities of OSA and HCs. Indexes correlated with measures of cognitive function, and changes in indexes and improvement in cognitive performance were observed after treatment in participants with moderate OSA. © RSNA, 2024 . See also the editorial by Port in this issue.